Cite
HARVARD Citation
Glennon, K. et al. (n.d.). 128 In silico analysis of the immune checkpoint TIGIT as a novel immunotherapy target for high grade serous ovarian cancer. International journal of gynecological cancer. p. A57. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Glennon, K. et al. (n.d.). 128 In silico analysis of the immune checkpoint TIGIT as a novel immunotherapy target for high grade serous ovarian cancer. International journal of gynecological cancer. p. A57. [Online].